Aegerion Pharmaceuticals, Inc. (AEGR) Observes Rare Disease Day
2/28/2014 10:00:41 AM
CAMBRIDGE, Mass., Feb. 28, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating rare diseases, announced today its alliance with the National Organization for Rare Disorders (NORD), Rare Diseases Europe (EURORDIS) and Canadian Organization of Rare Disorders (CORD), and The Global Genes Project in observance of the annual Rare Disease Day.
Help employers find you! Check out all the jobs and post your resume.